BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7199253)

  • 1. Serological investigation and clinical significance of high-titer, low-avidity (HTLA) antibodies.
    Moulds MK
    Am J Med Technol; 1981 Oct; 47(10):789-95. PubMed ID: 7199253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serology of the York-Cost-McCoy-Knops red blood cell system.
    Molthan L
    Am J Med Technol; 1983 Jan; 49(1):49-56. PubMed ID: 6846382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-KANNO: a novel alloantibody against a red cell antigen of high frequency.
    Kawabata K; Uchikawa M; Ohto H; Yasuda H; Tsuneyama H; Tsuchida H; Ito S
    Transfus Med Rev; 2014 Jan; 28(1):23-8. PubMed ID: 24485899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of complement in immunohematology.
    Garratty G
    Crit Rev Clin Lab Sci; 1984; 20(1):25-56. PubMed ID: 6373144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic disease of the fetus and newborn due to anti-Ge3: combined antibody-dependent hemolysis and erythroid precursor cell growth inhibition.
    Blackall DP; Pesek GD; Montgomery MM; Oza KK; Arndt PA; Garratty G; Shahcheraghi A; Denomme GA
    Am J Perinatol; 2008 Oct; 25(9):541-5. PubMed ID: 18720327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Knops blood group antigens on CR1 (CD35) by the MAIEA test and by immunoblotting.
    Petty AC; Green CA; Poole J; Daniels GL
    Transfus Med; 1997 Mar; 7(1):55-62. PubMed ID: 9089986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemolytic disease of newborn infants caused by anti-Diego antibodies].
    Monestier M; Rigal D; Meyer F; Juron-Dupraz F; Baboin-Jaubert M; Marseglia GL
    Arch Fr Pediatr; 1984 Nov; 41(9):641-3. PubMed ID: 6542344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemolytic disease of the newborn due to a new red cell antigen 'Pollio'.
    McClelland WM; McLaughlin KG; Poole J; Giles CM
    Clin Lab Haematol; 1982; 4(2):201-3. PubMed ID: 7116800
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemolyzing antibodies to markers of the P blood factor system as a problem in blood transfusion and pregnancy. With reference to serology, biochemistry and genetics].
    Pausch V; Speiser P; Michl U; Höcker P; Engelfriet CP
    Wien Klin Wochenschr; 1990 Feb; 102(3):80-90. PubMed ID: 2316222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-titer, low-avidity (HTLA) antibodies and antigens: a review.
    Rolih SD
    Transfus Med Rev; 1989 Apr; 3(2):128-39. PubMed ID: 2520549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of hemolytic disease of the newborn caused by anti-M: serological study of maternal blood.
    Matsumoto H; Tamaki Y; Sato S; Shibata K
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):525-8. PubMed ID: 7195138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohematology.
    Virella G; Spivey MA
    Immunol Ser; 1993; 58():361-78. PubMed ID: 8424983
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of hemolytic disease of the newborn due to anti-Dib antibodies.
    Uchikawa M; Shibata Y; Tohyama H; Mori H; Aisaka K; Nakagawa M
    Vox Sang; 1982 Feb; 42(2):91-2. PubMed ID: 7199783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhesus and other antibodies.
    O'Sullivan JF
    Clin Obstet Gynaecol; 1982 Apr; 9(1):91-9. PubMed ID: 6809392
    [No Abstract]   [Full Text] [Related]  

  • 16. The first example of anti-Dia antibody in Poland.
    Kuśnierz-Alejska G; Bochenek S; Zukowska B
    Mater Med Pol; 1990; 22(1):15-6. PubMed ID: 2079854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn.
    Sacks DA; Nance SJ; Garratty G; Petrucha RA; Horenstein J; Fotheringham N
    Am J Perinatol; 1993 Nov; 10(6):428-31. PubMed ID: 8267805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perinatal hemolytic disease. Part 1: physiopathology].
    Wirthner D; Hohlfeld P; Tissot JD
    J Gynecol Obstet Biol Reprod (Paris); 1998 Mar; 27(2):135-43. PubMed ID: 9599759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.